Literature DB >> 33161440

177Lu-PSMA for advanced prostate cancer: are we ready to play big?

Charisma Hehakaya1, Ellen H M Moors2, Helena M Verkooijen3, Diederick E Grobbee4, Frederik A Verburg5, Marnix G E H Lam3.   

Abstract

Entities:  

Year:  2021        PMID: 33161440     DOI: 10.1007/s00259-020-05102-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  2 in total

1.  Lutetium-177-PSMA-617: A Vision of the Future.

Authors:  Elias Chandran; William D Figg; Ravi Madan
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.742

2.  Preparation of 177Lu-PSMA-617 in Hospital Radiopharmacy: Convenient Formulation of a Clinical Dose Using a Single-Vial Freeze-Dried PSMA-617 Kit Developed In-House.

Authors:  Mohini Guleria; Jeyachitra Amirdhanayagam; Haladhar D Sarma; Ramya Priya Rallapeta; V S Krishnamohan; Ajit Nimmagadda; Parthasarathy Ravi; Sailaja Patri; Tekchand Kalawat; Tapas Das
Journal:  Biomed Res Int       Date:  2021-11-20       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.